dangers of taking glp-1 Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus Improved Heart and Kidney Outcomes

10.1111/j.1369-1600.2010.00280.x 164 LappalainenJ.KranzlerH

This study will also have useful clinical implications in reducing the gut microbiota caused variation in the drug response among different populations

Tirzepatide is a related drug that mimics GLP-1 as well as a hormone called a glucose-dependent insulinotropic polypeptide (GIP)

This evaluation should include discussion of any ongoing digestive symptoms you experience following your cholecystectomy, such as diarrhoea, bloating, or difficulty tolerating certain foods

Its deficiency is extremely uncommon among healthy individuals, but is associated with certain diseases that impair the digestion or absorption of fat